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Gatter et al. (1985) advocate the use of monoclonal
antibodies (McAb) to leucocyte common antigen
(LCA) and to intermediate filament cytokeratins
(Cytok) to distinguish lymphoma (LCA+ Cytok-)
from carcinoma (Cytok+ LCA-) in the differential
diagnosis of anaplastic tumours. We report here a
case ultimately diagnosed as an IgD myeloma
where the tumour in the presenting lesion (an
enlarged cervical lymph node) clearly expressed
LCA and Cytok in the same cells. To our
knowledge this is the first such reported
observation.
The patient, a 42 year old man, presented with a
6 month history of enlarged lymph nodes in the
neck and weight loss of 10kg. On examination,
there was mild hepatosplenomegaly and CAT scan
demonstrated a mediastinal mass. A cervical lymph
node biopsy was formalin fixed, and paraffin
sections submitted to histopathological analysis.
The histopathologist diagnosed an anaplastic
tumour, and suggested an immunoblastic
lymphoma (Keil classification). As part of our
routine protocol sections were trypsinised and
immunostained using a conventional indirect
immunoperoxidase method with antibodies to LCA
(Dakopatts a/c) and to Cytok (Becton-Dickinson-
Clone CAM 5:2). The results showed the tumour
cells positive for both markers. Concurrent positive
and negative tissue controls were performed.
More extensive immunostaining was done on the
paraffin sections using McAb and polyclonal
antibodies to immunoglobulin (Ig) heavy chains
(IgD, IgM, IgG, IgA and IgE) and to light chains
kappa (K) and lambda (A) (Unipath). The tumour
cells (LCA+ Cytok+) was positive for A light
chains, no Ig heavy chain isotype was detected.
In view of the unique dual phenotype of the
tumour cells detected in the fixed tissue, a fresh
unfixed second lymph node biopsy was requested.
Non-enzyme treated, cryostat sections were acetone
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fixed and stained by the indirect immunoperoxidase
technique with the panel of antibodies listed with
additional McAb to T cell, B cell, monocyte and
myeloid markers. Controls included omission of
primary layers and replacement of primary
antibodies by normal mouse immunoglobulin. The
results on the cryostat sections also showed the
tumour cells positive for LCA, Cytok, A chains and
additionally all the tumour cells were positive for
IgD heavy chain with McAb and polyclonal anti
IgD antibodies (see Figure 1). The finding of
positive staining for IgD on the cryostat sections
with negative results on the fixed trypsinised
sections is compatible with the knowledge that IgD
antigenic determinants are very susceptible to
denaturation by formalin, heat and trypsin (Jefferis
& Mathews, 1977). We have also performed double
immunoenzyme and immuno-fluorescent staining
which clearly demonstrates that single tumour cells
express LCA, Cytok, IgD and A chains.
Further investigations demonstrated Bence-Jones
(BJ) proteinuria, a minor elevation of the serum
creatinine and multiple bone lesions on bone scan.
The serum calcium was normal. Serum IgD was
detected by immunoelectrophoresis but a para-
protein band was not evident by zone electro-
phoresis. The IgM, IgG, IgA serum levels were in
the normal range. Bone marrow aspirate showed
increased numbers of IgD (A) cells. The patient
findings thus fulfilled MRC criteria for a diagnosis
of myeloma. The marrow IgD cells were also posi-
tive for Cytok. Control marrows were uniformly
negative for Cytok. The patient was treated with
a high dose of i.v. melphalan which resulted in
rapid resolution of the lymphadenopathy. The BJ
proteinuria subsequently disappeared; he continues
on chemotherapy.
From our frozen tissue stores unequivocal cases
of anaplastic carcinoma (8 cases Cytok+, LCA-)
are clearly negative for IgD. We have not at
present any preparations of fresh IgD myeloma
cells to test the converse.
This unique case illustrates that malignant cells
can on rare occasions break the phenotypic rules;
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Figure 1 Immunostaining of lymph node with antibodies to (a) Leucocyte common antigen (LCA) (b)
Cytokeratin (c) IgD heavy chain (d) T lymphocyte antigen (CD2). The anaplastic tumour cells (large cells,
immunoblasts) clearly stain for LCA, Cytokeratin and IgD (staining for Lambda light chains was identical to
IgD). The pan T cell antibody CD2 (Dako Ti11) stains only the scattered residual small lymphocytes, which
also stain strongly for LCA in (a). The large tumour cells are unstained by the CD2 antibody. (Mag. (a) and
(d) x450, (b) and (c) x720).
this is not unprecedented. Epithelial membrane
antigen has been shown to be expressed by a small
percentage of lymphomas/myeloma (Delsol et al.,
1984); lymphoid malignancies have been
documented which express myeloid markers (Smith
et al., 1983). Even at the genotypic level using
cDNA probes to Ig and T cell receptor genes, a
small percentage of lymphoid tumours can be
shown to have both T cell and Ig gene
rearrangements in the same cells (Pelicci et al.,
1985).
Clearly by clinical and laboratory results our
patient has myeloma. Whether the Cytok positivity
of his tumour cells merely reflect an isolated
malignant aberrant gene expression or may have
biological/clinical significance and/or a particular
association with IgD tumours must await further
investigations and observations.
Finally, when investigating anaplastic tumours by
immunophenotyping it is important that both
antibodies (LCA and Cytok) be used. It should be
stressed that this unusual case does not undermine
the established usefulness of these antibody markers
in the differential diagnosis of anaplastic tumours.
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